Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of topical KP-607 in patients with onychomycosis (Phase II)
jRCT2080225203Phase 2Completed
- Sponsor
- KAKEN PHARMACEUTICAL CO., LTD.
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of KP-607 in onychomycosis (3 arms), sponsored by KAKEN PHARMACEUTICAL CO., LTD. Started May 2020; status: completed.
02
Drugs
KP-607
03
Conditions
onychomycosis
Beyond the preview
Go deeper on jRCT2080225203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225203.